MedPath

study of causes of hyperlipidemia and correlation with obesity

Not Applicable
Conditions
Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Registration Number
CTRI/2022/04/042125
Lead Sponsor
DYPatil college of ayurved and research centrepune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Group A

New diagnosed patients

total cholesterol -above-200mg/dl

s.triglycride-above-160mg/dl

BMI-Above25

Group B

New diagnosed patients

total cholesterol -below-200mg/dl

s.triglycride-below-160mg/dl

BMI-below25

Exclusion Criteria

AGE-more than 60 year

less than 30 year

Any major illness like maglignancy,serious cardiac problem like IHD,MI,Hypothyroididsm,pregnancy,HIV,Autoimmune disease and uncontrolled DM

Drug induced hyperlipidaemia .eg Glucocorticoid ,diuretics.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the etiological factors of Medoroga and etiological factors of hyperlipidemia. <br/ ><br>Timepoint: OBSEVATINAL-4 WEEKs <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To find of the association in between medoroga and hyperlipidemia based on the etiological factors and signs and symptoms <br/ ><br>Timepoint: OBSERVATIONAL-4 WEEKS
© Copyright 2025. All Rights Reserved by MedPath